🇬🇧 Read this article in English
NutriCellScience scientific review — version 1.0 — July 20, 2026
Medical disclaimer. This review is informational; it replaces neither a diagnosis nor a medical consultation. New or persistent erectile dysfunction may reveal cardiovascular, metabolic, neurological, hormonal, or anatomical disease. Never stop a suspected medication on your own. Chest pain, unusual shortness of breath, or feeling faint during sexual activity warrant urgent evaluation. A painful erection lasting four hours or more is an emergency.
Summary
Erectile dysfunction (ED) is the persistent inability to obtain or maintain an erection sufficient for satisfactory sexual activity. It is neither a single etiological diagnosis nor an inevitable consequence of aging: it is a symptom arising from interactions between the nervous system, the vascular endothelium, cavernosal smooth muscle, hormones, mental health, the couple’s relationship, and social context. Mixed forms are more common than “purely organic” or “purely psychological” forms.
Can it be treated without medication? Yes, in some situations, but not with a universal method. Regular aerobic physical activity has the most consistent data among restorative strategies: a meta-analysis of 11 randomized trials reports a mean improvement of 2.8 points in the erectile function domain of the International Index of Erectile Function (IIEF-EF), with a more marked effect when the baseline difficulty is more severe. In men who are overweight or obese, weight reduction achieved through an intensive intervention on diet and physical activity can improve erectile function; the mean effect is nonetheless modest and depends on the weight loss actually achieved. Smoking cessation, reduction of excessive alcohol intake, and management of diabetes, hypertension, dyslipidemia, and obstructive sleep apnea syndrome correct determinants of ED, even when the direct erectile benefit is imperfectly quantified.
Cognitive behavioral therapy focused on sexuality, sex therapy, and couple-based work are particularly relevant when performance anxiety, avoidance, relationship conflict, or situational variability maintain the difficulty. The evidence for them is probable, but the trials are fewer and more heterogeneous than for exercise. Pelvic floor muscle training can help some men, particularly when a neuromuscular deficit is objectively documented or after certain surgeries; the protocols are not standardized, however, which precludes presenting generic “Kegel exercises” as a demonstrated solution for everyone.
The vacuum erection device — or vacuum — is an effective non-drug option for mechanically producing an erection. Its functional efficacy can be high in well-trained users, but acceptability, spontaneity, bruising, the sensation of coldness, and long-term discontinuation limit its use. It assists the erection without necessarily restoring the causal mechanism. Focal low-intensity extracorporeal shockwave therapy may provide a small benefit in some mild vasculogenic ED; certainty remains low, protocols are heterogeneous, and the improvement may remain below the perceptible threshold. Supplements — L-arginine, ginseng, and various combinations — rest on modest, often fragile signals and expose users to uncertain product quality. Products sold as “natural sexual stimulants” may covertly contain pharmacological substances.
The most rational strategy therefore does not pit “natural” against “medication.” It starts by identifying the dominant mechanism, assessing cardiovascular risk, treating causal diseases, defining the goals of the person and the couple, then testing a targeted, measurable combination for about twelve weeks. In case of erectile failure, severe ED, pain, new curvature, neurological involvement, suspected hypogonadism, or pelvic surgery, specialist advice should not be delayed.
Keywords: erectile dysfunction; exercise; endothelium; cardiovascular risk; sex therapy; pelvic floor; vacuum; shockwave therapy; sleep; nutrition.
Key points
- Established: ED warrants medical and cardiovascular evaluation; regular aerobic exercise modestly improves erectile function; the vacuum erection device can produce a usable erection.
- Probable: weight loss in men with excess weight and targeted psychosexual interventions improve some presentations; correction of cardiometabolic factors is a therapeutic foundation.
- Emerging: pelvic floor muscle training in selected subgroups and focal low-intensity shockwave therapy.
- Hypothetical or insufficient: most supplements, acupuncture, traction devices for isolated ED, and standardized, non-personalized programs.
- To be avoided: non-medically supervised yohimbe and “natural” sexual performance products without traceability.
Introduction: one symptom, several possible diseases
An erection is a biological event that is spectacular in its speed but fragile in the number of systems that must cooperate. The brain must interpret a stimulus as sexually relevant; the autonomic nerve pathways must transmit the signal; the endothelium and nerve endings must release nitric oxide; the smooth muscle of the corpora cavernosa must relax; arterial inflow must increase; and finally, tissue expansion must compress the draining veins to maintain rigidity. Moderate disruption at several levels is enough to tip the whole system.
This architecture explains why ED is often mixed. A man with diabetes may accumulate endothelial damage, neuropathy, deconditioning, anxiety, and marital tension. Moreover, the first erectile failure can create a maintaining loop: attention shifts away from pleasure to monitoring the erection, sympathetic activation increases, and the next erectile failure appears to confirm an incapacity.
The term “erectile dysfunction” implies a repeated and distressing problem, not an occasional erectile failure after fatigue, stress, or alcohol intake. Severity is often measured with the IIEF or its abbreviated five-question version, the Sexual Health Inventory for Men (SHIM/IIEF-5). These tools objectively document change but do not replace the clinical interview: they poorly capture desire, pleasure, communication within the couple, pain, sexual practices, and the personal priority given to penetration.
The therapeutic goal should not be only an increase in score. It may be regaining sufficient rigidity, reducing the fear of erectile failure, resuming non-penetrative intimacy, or restoring spontaneity. This plurality guides the choice of interventions.
The erection, a neurovascular response modulated by context
Biological basis: where can non-pharmacological approaches act?
Endothelium and nitric oxide
The endothelium lines the blood vessels and regulates their dilation. In response to blood flow and neuronal signals, it produces NO via endothelial nitric oxide synthase. NO diffuses into the smooth muscle, activates guanylate cyclase and promotes the accumulation of cGMP. Intracellular calcium falls, the muscle relaxes and the penile arteries dilate.
Hypertension, hyperglycemia, excess atherogenic lipids, smoking, chronic inflammation and physical inactivity impair this function. The penis may then become an early indicator of diffuse vascular damage. Because the penile arteries are of smaller caliber than the coronary arteries, the same atherosclerotic burden may become apparent there earlier. This model is not absolute, but it supports the message of the Princeton IV consensus: ED, especially vasculogenic ED, should be regarded as a marker that increases cardiovascular risk, and not as an isolated problem.
Exercise, smoking cessation, and improvement in blood pressure, blood glucose and the lipid profile therefore target common ground. Their value goes beyond sexuality: they reduce the risk of cardiovascular disease, improve exercise capacity and may increase NO availability. This mechanistic convergence makes lifestyle intervention rational even when its average effect on erectile score remains modest.
Autonomic nervous system and neurological integrity
Erection depends on a balance between parasympathetic activation, which promotes vasodilation, and sympathetic activation, which contributes to detumescence. Spinal cord injury, diabetic neuropathy, pelvic or prostate surgery and certain neurodegenerative diseases can interrupt the required pathways. Conversely, preserved neurological integrity does not prevent sympathetic activation induced by fear, shame or hypervigilance from blocking the response.
This point avoids two symmetrical errors: psychologizing neurological ED, and treating anxiety as insignificant when organic damage is present. A psychosexual factor can amplify vascular ED; psychological improvement can therefore provide real benefit without “inventing” the organic component.
Smooth muscle, cavernosal architecture and pelvic floor
Rigidity requires cavernosal tissue capable of filling and of limiting venous return. The ischiocavernosus muscle increases intracavernosal pressure during the rigid phase; the bulbospongiosus is involved in ejaculation. Well-conducted training can improve the recruitment and coordination of these muscles. However, contracting more is not always the solution: some patients have, on the contrary, a pelvic floor that is overly tense, painful or poorly coordinated. Assessment by a physiotherapist trained in male pelvic health is preferable to a generic prescription of repeated contractions.
Fibrosis, significant veno-occlusive leakage, Peyronie’s disease or postsurgical sequelae can limit the response to lifestyle measures alone. In these cases, prudence consists of recognizing early the need for a urological opinion.
Hormones, desire and metabolism
Testosterone supports desire, tissue trophicity and certain steps of erectile signaling, but ED is not equivalent to testosterone deficiency. A decline in desire, fewer spontaneous erections, unusual fatigue, reduced body hair or infertility may justify a fasting morning measurement. A low result generally needs to be confirmed and interpreted together with SHBG, the gonadotropins and the clinical context.
Obesity, diabetes, lack of sleep, certain opioids and the use of anabolic steroids can disturb the hormonal axis. Weight loss and treatment of obstructive sleep apnea syndrome can improve the endocrine context, but do not remove the need for a diagnosis when hypogonadism is suspected.
Before “treating naturally”: establish the phenotype and safety
The clinical interview that changes management
A high-quality consultation clarifies the onset, progression, rigidity and duration of erections, their presence in the morning or during masturbation, their variability according to context or partner, as well as desire, orgasm, ejaculation and pain. An abrupt onset, preserved morning erections and a strong dependence on context point toward a psychosexual component, without proving it. A gradual, consistent onset associated with cardiometabolic risk factors points toward a vascular component.
The clinician also looks for depression, anxiety, trauma, relationship difficulties, infertility, pelvic pain, penile curvature, urinary symptoms, neuropathy, pelvic surgery or radiotherapy. The examination includes at a minimum blood pressure, heart rate, body mass index or waist circumference, then a targeted genitourinary, endocrine, vascular and neurological examination.
The guidelines of the European Association of Urology generally recommend a fasting blood glucose or HbA1c, a lipid profile and a morning total testosterone. Depending on the context, calculated free testosterone or SHBG, LH, FSH, prolactin, TSH, and renal or hepatic function are added. Not all men need penile Doppler ultrasound; it is reserved for specific diagnostic or therapeutic questions.
Reviewing medications without stopping them
Some treatments can contribute to ED: several antihypertensives, notably thiazides or certain beta-blockers; serotonergic antidepressants; antipsychotics; antiandrogens; 5-alpha-reductase inhibitors; opioids. The relationship is never automatic: the treated disease may itself be responsible, and the effect varies with the drug. Abruptly stopping an antihypertensive or a psychotropic drug can be dangerous. The right approach is a review with the prescriber: current indication, timing, dose, possible alternatives and benefit-risk balance.
Assessing cardiovascular risk and fitness for sexual activity
Sexual activity usually represents moderate exertion, but safety depends on cardiovascular stability. Controlled hypertension, mild valvular disease or stable heart failure of functional class I–II are generally compatible with sexual activity. Unstable angina, uncontrolled hypertension, severe heart failure, high-risk arrhythmia or a very recent untreated myocardial infarction require sexual activity and intense training to be deferred until stabilization.
In a man who is asymptomatic but has vasculogenic ED, overall cardiovascular risk should be estimated. Princeton IV regards ED as a factor that strengthens risk; in some men at borderline or intermediate risk, a coronary calcium score can refine the preventive decision. This is not an automatic test: the decision depends on the context.
Treat the dominant mechanism, not just the symptom
Act on: exercise, targeted weight loss, smoking, diabetes and blood pressure.
Act on: psychoeducation, CBT, sex therapy and couple-based work.
Act on: specialized pelvic floor muscle training, biofeedback, vacuum erection device and urological opinion.
Act on: confirm the cause, review prescriptions without stopping them on your own.
Mixed forms are the rule: several axes can be addressed simultaneously.
Physical activity: the best-supported restorative strategy
What the trials show
The most informative synthesis pooled 11 randomized controlled trials evaluating aerobic exercise. Compared with no exercise, the mean improvement reached 2.8 points on the IIEF-EF (95% confidence interval: 1.7 to 3.9). The effect varied with baseline severity: about 2.3 points in mild cases, 3.3 in moderate cases and 4.9 in severe cases. Physical activity can therefore produce a measurable improvement; it does not guarantee normalization or a sufficient response for everyone.
The clinical significance deserves nuance. Minimal thresholds for perceptible change on the IIEF-EF, derived mainly from drug trials, have been estimated at around 2 points for mild ED, 5 for moderate ED and 7 for severe ED. These thresholds are neither universal nor interchangeable with satisfaction. The average effect of exercise may therefore be perceptible in some men and insufficient in others, particularly when ED is moderate or severe.
Trials cannot blind participants, which favors expectation bias, and they combine different populations, intensities and durations. The consistency of the results and the independent cardiometabolic benefits nevertheless justify classifying aerobic activity as an established intervention.
A practical prescription
Effective protocols often use 30 to 60 minutes of aerobic activity, three to five times per week, for a total of around 150 to 160 minutes weekly. Brisk walking, cycling, swimming, rowing or dancing may all be suitable. Moderate intensity corresponds approximately to an effort that allows you to speak in sentences but not to sing easily. Consistency matters more than the perfect modality.
In a sedentary person, starting with 10 to 15 minutes of walking and progressing each week improves adherence. Two resistance training sessions usefully complement the program, even though the specific erectile evidence for them is less direct. The first changes may appear within eight to twelve weeks; a more complete adaptation often takes three to six months.
Training must be individualized in the presence of chest pain, unexplained dyspnea, faintness, unstable cardiovascular disease, severe neuropathy, proliferative diabetic retinopathy or orthopedic limitation. “Getting some exercise” is not a substitute for the evaluation of ED, which may reveal silent disease.
Weight, diet and metabolic health
Losing weight when excess weight is present
The landmark trial by Esposito and colleagues included 110 obese men with ED and without diabetes, hypertension or hyperlipidemia. After two years, an intensive intervention targeting weight loss, better diet and more physical activity normalized erectile function in 31% of participants, versus 5.5% in the control group. The IIEF score improved by about 3.1 points in the intervention group. This result is encouraging, but it comes from a selected subgroup and combines several changes; it does not allow the effect to be attributed to diet alone.
A meta-analysis of weight-loss trials estimates a mean improvement of close to 2 points. The appropriate conclusion is probable in overweight or obese men, not “demonstrated for everyone.” A person of normal weight should not lose weight in order to treat their ED. The goal is to reduce visceral adiposity, insulin resistance and inflammation.
A loss of 5 to 10% of initial body weight is often a realistic metabolic target. Effective strategies rely on a moderate energy deficit, satiating foods, adequate protein intake, fiber, a supportive food environment and follow-up. Very restrictive diets can reduce energy, increase body-image concerns and degrade sexual life; they are not necessary.
Mediterranean diet: plausible, healthy, but not an aphrodisiac
The Mediterranean pattern favors vegetables, whole fruit, legumes, minimally refined grains, nuts, olive oil, fish and minimally processed foods. It improves several cardiovascular determinants of endothelial function. In trials among men with metabolic syndrome or newly diagnosed diabetes, this pattern was associated with less deterioration or with an improvement in sexual function. It remains difficult to separate the effect of weight loss, physical activity and intensive support.
The recommendation is therefore indirect but solid for overall health: adopt this pattern in order to address cardiometabolic risk, with a possible erectile benefit. No single food — oyster, cocoa, pomegranate, beetroot or spice — has demonstrated an effect comparable to a comprehensive strategy. Dietary nitrates from beetroot may influence systemic vasodilation; specific clinical evidence in ED remains insufficient.
Diabetes, blood pressure and lipids
Elevated HbA1c, uncontrolled hypertension and high LDL cholesterol damage vessels and nerves. Managing them may slow the progression of ED and reduce cardiovascular risk. However, it would be misleading to promise that late control will always restore normal erectile function: some structural damage is poorly reversible.
The “without medication” discussion must not lead to refusing an indicated cardiometabolic treatment. A lipid-lowering, antihypertensive or antidiabetic drug may protect future vascular function more than avoiding it would. The priority is overall optimization, choosing where possible molecules that are neutral or favorable for sexual function when several equivalent options exist.
Tobacco, alcohol, sleep and substances
Tobacco
Tobacco reduces NO bioavailability and promotes oxidative stress, atherosclerosis and vasoconstriction. Prospective studies show an improvement in erectile function after cessation in a proportion of men, especially when they are younger and the difficulty is less severe. The interventional evidence is less robust than for exercise, but the vascular causality and the cardiovascular benefit of cessation are established.
Minimal advice should be replaced by structured support: a quit date, behavioral support, management of triggers and, if necessary, nicotine replacement or prescribed treatment. If the editorial aim is “without medication for ED,” this does not preclude pharmacological help for smoking cessation when it substantially increases the chances of success.
Alcohol and drugs
Low alcohol consumption is not a treatment. Heavy consumption disrupts arousal and promotes liver damage, neuropathy, hormonal disorders and relationship difficulties. In men with dependence, abstinence has been associated with an improvement after three months, but studies without a control group do not allow the effect to be quantified reliably.
Cannabis, cocaine, amphetamines, opioids and anabolic steroids can affect desire, hormones, vascular supply or mental health. Confidentiality and a non-judgmental approach are essential to obtain the real history.
Sleep and obstructive sleep apnea
Nocturnal erections are linked to sleep architecture. Chronic lack of sleep disrupts mood, desire, the autonomic nervous system and metabolism. Obstructive sleep apnea (OSA) combines repeated hypoxia, oxidative stress and cardiovascular risk; it should be looked for in cases of snoring, observed breathing pauses, sleepiness, resistant hypertension or obesity.
Continuous positive airway pressure (CPAP) treats OSA and reduces certain risks; its mean erectile effect appears small and the certainty is low according to reviews. It should therefore be offered for OSA, not as an erectile device. Nightly adherence, weight loss where indicated and treatment of nasal obstruction determine the outcome.
Psychosexology: breaking the performance–failure loop
When a psychosexual component is likely
Marked variability, preserved erections on waking or during masturbation, onset after a stressful event, ED limited to certain situations, an intense fear of losing the erection, or relationship conflict all suggest a psychosexual component. None of these signs is sufficient on its own. Organic mechanisms may coexist and be amplified by anxious self-monitoring.
Sexually focused cognitive behavioral therapy addresses automatic thoughts (“I have to be hard immediately,” “if the erection fades, everything is over”), self-observation, avoidance, and shame. It may incorporate psychoeducation, breathing, cognitive restructuring, graded exposure, communication, and sensory focusing exercises — sensate focus — in which the couple explores touch with no initial goal of penetration or erection.
Couple-based interventions shift success away from a binary indicator and toward a shared experience. They clarify preferences, reduce interpretation of the difficulty as a lack of desire, and lower pressure. They are particularly useful when the partner unintentionally adopts an attitude of monitoring or avoidance.
Level of evidence and limitations
A systematic review of psychological interventions concludes that combining them with PDE5 inhibitors often outperforms either modality alone for erectile function and long-term satisfaction. The stricter question of therapy without medication rests on fewer trials. Populations, formats, therapist skills, cultures, and outcome measures differ; several studies are small and at risk of bias.
We therefore classify psychosexual intervention as likely, with strong clinical relevance in psychogenic or mixed ED. This classification does not mean the effect is small; it means that its average quantification is less certain. A consultation with a psychologist, psychiatrist, or sexologist with recognized clinical training is preferable to commercial programs promising a rapid cure.
Depression, anxiety disorder, trauma, or sexual violence require specific management. Sex therapy does not replace treatment of a severe depressive episode or the assessment of suicide risk.
Pelvic floor muscle training
The ischiocavernosus and bulbospongiosus muscles contribute to rigidity and to ejaculation. A few trials, including one randomized trial using biofeedback, have reported improvement after several months of exercises. Systematic reviews consider the strategy promising, but emphasize the low rigor of some studies and the absence of an optimal protocol. A more recent meta-analysis of physical activities did not demonstrate a significant effect of pelvic floor training when it was isolated from pharmacological treatments.
The conclusion is emerging to likely in subgroups, not established for all ED. The best candidates are men with poor contraction, deficient coordination, sequelae of prostatectomy, or certain associated pelvic symptoms. Pelvic pain, difficulty relaxing, or hypertonicity may worsen with intensive unsupervised contractions.
The clinician assesses contraction, endurance, relaxation, and breathing; palpation, biofeedback, or functional ultrasound may be used. A typical program combines brief and sustained contractions, complete relaxation, and functional integration, but the dose must remain individualized. Progress is assessed over at least three months.
The vacuum erection device: a mechanical, non-drug aid
The vacuum device places the penis in a cylinder. A pump removes the air, creates negative pressure, and draws blood into the tissues. A constriction ring placed at the base limits venous return. Unlike restorative interventions, the effect can be immediate and does not depend entirely on NO; it remains usable across a range of causes, including after surgery or when medications are contraindicated.
European guidelines report up to 90% satisfactory erections in some series, but satisfaction varies widely and long-term use declines. The success figure depends on the definition, on training, on selection, and on partner involvement. An erection obtained with a vacuum device may be colder, purplish, less natural, with numbness, pain, bruising, or impaired ejaculation. These effects explain why technical efficacy is not synonymous with acceptability.
Learning to use the device is central: choose a medical device with a pressure limiter, use a lubricant for the seal, pump gradually, and select the loosest ring that maintains the erection. The ring must not be left in place for more than 30 minutes, and you must never sleep with it on. A penis that is cold, numb, very dark, or painful requires removal of the ring; if it is stuck, seek emergency care.
Heightened caution applies in cases of anticoagulant treatment, bleeding disorder, sickle cell disease, or altered penile sensation. Guidelines diverge between contraindication and precaution depending on severity: clinician advice is necessary. The vacuum device is classified as established as a mechanical aid, but it does not demonstrate durable spontaneous restoration.
Low-intensity shockwave therapy: biological promise, low certainty
Focal low-intensity extracorporeal shockwaves (Li-ESWT) deliver acoustic energy to penile tissue. The hypothesis is stimulation of angiogenesis, remodeling, and endothelial function. The candidates studied are mainly men with mild to moderate vasculogenic ED.
Earlier meta-analyses reported gains of about three IIEF points. The 2025 Cochrane review concludes that there is a small short-term benefit, possibly too small to be perceived, and an uncertain longer-term benefit. Certainty is low because of small trials, differing protocols, risk of bias, short follow-up, and incomplete results on satisfaction and quality of life. The EAU guidelines grant only a weak recommendation in selected situations; the American Urological Association has historically considered the method experimental.
True focal shockwaves must be distinguished from “radial acoustic waves” marketed under similar terms without demonstrated equivalence. The number of sessions, energy density, number of pulses, treated sites, and maintenance are not standardized. Honest consent must specify the cost, the uncertainty, the absence of any guarantee, and the possibility of a transient effect. We classify Li-ESWT as emerging, never as a mandatory first step.
Dietary supplements and so-called natural therapies
L-arginine and NO precursors
L-arginine is a substrate for NO synthesis. Trials and meta-analyses suggest a small gain in IIEF scores, especially at high doses or in combination products, but no robust improvement in satisfaction. Formulations and populations vary; small positive trials dominate the literature. The EAU cautiously considers L-arginine or ginseng in selected men with mild ED who decline pharmacologic treatment, while stating that any benefit is only possibly slight.
L-arginine can cause digestive upset and a drop in blood pressure, interact with antihypertensives, nitrates and other vasodilators, and be problematic after certain cardiovascular events. L-citrulline, which is converted to arginine, has biological plausibility but insufficient clinical evidence to draw conclusions.
Ginseng, saffron, maca and blends
Ginseng has been studied in randomized trials, but evidence syntheses judge the effect small or trivial, with low certainty. Saffron, maca, Tribulus terrestris, pycnogenol combined with arginine and various plants have preliminary signals that are not sufficient to recommend routine clinical use. The issues include small sample sizes, multiple outcomes, lack of independent replication, heterogeneous doses and selective publication.
The word “natural” says nothing about either efficacy or safety. Yohimbe can cause hypertension, tachycardia, anxiety and arrhythmias; it should not be used for self-medication. Health agencies regularly identify “sexual performance” products containing undeclared analogues of PDE5 inhibitors. These adulterations expose users to serious interactions, in particular with nitrates, and make dose control impossible.
In practice, a supplement should be discussed only after the workup, with a traceable product, a known dose, a defined trial duration and predefined stopping criteria. None should delay cardiovascular evaluation or replace treatment of an underlying cause.
Expected benefit and strength of the evidence
| Intervention | Expected benefit | Certainty | Clinical interpretation |
|---|---|---|---|
| Aerobic exercise | Modest to moderate | Established | Best evidence–safety trade-off |
| Cardiovascular risk factors | Variable | Established | Major overall benefit |
| Psychosexual therapy | Modest to moderate | Probable | Especially with anxiety or mixed forms |
| Vacuum device | High, mechanical | Established | Assistance, not causal restoration |
| Shockwave therapy | Small | Emerging | Effect sometimes not perceptible |
| Supplements | Small | Low | Variable quality and safety |
What is not demonstrated — and what must not be delayed
Acupuncture lacks convincing trials. Penile traction is useful in some curvatures, but does not treat isolated ED. Platelet-rich plasma injections and stem cells are invasive and experimental; the EAU considers the evidence insufficient for routine practice.
Severe ED of sudden onset after trauma, pain, a new curvature or plaque, a testicular mass, a neurological deficit, complete absence of spontaneous erections, associated infertility or suspected hypogonadism all warrant referral. After prostatectomy, radiotherapy or rectal surgery, early rehabilitation discussed with the specialist team avoids losing time. Declining medication is a legitimate choice; it must not become a refusal of diagnosis.
Building a personalized twelve-week program
A structured program turns a collection of tips into an interpretable clinical experiment. It does not promise a cure in twelve weeks; it looks for a signal of response, measures adherence and decides what comes next.
Week 0: establishing the baseline
Document SHIM/IIEF-5 or IIEF-EF, rigidity, maintenance, morning erections, satisfaction, distress, desire, relationship context and physical activity. Measure blood pressure, waist circumference or BMI; obtain the appropriate laboratory workup. Identify medications, tobacco, alcohol, sleep and cardiovascular symptoms. Define one observable primary goal: for example, maintaining sufficient rigidity in most intercourse attempts, reducing anxiety or resuming satisfying intimacy.
Weeks 1 to 4: introduce few actions, but make them concrete
Begin progressive aerobic activity aiming at 150 minutes per week, depending on safety and capacity. Add two strength-training sessions if possible. In men with excess weight, choose two or three sustainable dietary changes: vegetables at two meals, replacing sugar-sweetened beverages, smaller portions of ultra-processed foods, regular legumes or fish. Prepare for smoking cessation or reduce excessive alcohol intake with professional support.
If anxiety is dominant, schedule a psychosexual consultation and moments of intimacy without any obligation of penetration. If pelvic floor impairment is suspected, obtain an assessment before multiplying contractions. If immediate help is wanted and appropriate, learn to use the vacuum erection device.
Weeks 5 to 8: adjust rather than add
Check the actual dose of activity, not the intention. Someone who has completed only 40 minutes per week has not “failed” at exercise; the program may have been too ambitious or poorly integrated. Review fatigue, pain, enjoyment, fitness progress, sleep quality and effects on the relationship. Gradually increase duration or intensity. Revisit dietary obstacles and cessation support.
Track how often sexual situations occur without turning every encounter into a test. A variable erection does not invalidate progress: an increase in morning erections, in confidence or in the ability to regain arousal after a decline may precede any change in score.
Weeks 9 to 12: measure and decide
Repeat the same questionnaire under comparable conditions. Ask whether the benefit is perceptible and relevant. A small score improvement without any gain in satisfaction may lead to changing the goal; a stable score with a major reduction in distress may be clinically useful. Continue the measures that work beyond twelve weeks, because weight loss and cardiovascular remodeling take time.
If there is no improvement despite genuine adherence, reconsider the diagnosis, untreated factors, severity and the relationship. A urological or andrological opinion may include penile Doppler, additional hormonal testing or discussion of pharmacological and interventional options. Combining approaches is not a failure of the “natural” route: it is adaptation to the mechanism and to preferences.
A structured twelve-week trial, then a decision
Clinical applications across four common profiles
A 48-year-old man, sedentary, high waist circumference, progressive ED
The vasculometabolic phenotype is likely. Priorities: cardiovascular risk, blood pressure, HbA1c, lipids, morning testosterone, progressive exercise, a Mediterranean diet with a 5 to 10% weight loss if indicated, sleep and tobacco. ED serves as a lever for prevention, but no promise of normalization should be made. If rigidity remains insufficient, a vacuum erection device or medical treatment can be discussed in parallel.
A 32-year-old man, normal morning erections, erectile failure with a new partner
The psychosexual component probably dominates. Explain the monitoring loop, reduce the performance goal, and offer sensate focus and CBT/sex therapy. Nevertheless check history, substances, medications and a basic examination. An extensive workup is not always necessary, but a “psychological” diagnosis must not be made by default on the sole basis of age.
A 67-year-old man after prostatectomy
Nerve and tissue injury is plausible. Exercise and vascular health remain useful, but they are often not sufficient. A supervised rehabilitation strategy may combine a vacuum erection device, adapted pelvic work and other treatments discussed with the urologist. Data on the restoration of spontaneous erections through vacuum or traction devices remain uncertain; their role may be functional or one of tissue preservation.
A 56-year-old man, snoring, daytime sleepiness, resistant hypertension
Look for obstructive sleep apnea and assess cardiovascular risk. CPAP is indicated if the diagnosis confirms it, above all to treat the sleep disorder and its risks; erectile improvement is a possible but not guaranteed secondary benefit. Activity, weight loss if needed and optimization of hypertension complete the plan.
Limitations of the evidence
Research on non-pharmacological ED faces several difficulties. Participants cannot be blinded to exercise, to a therapy or to a vacuum erection device. Study populations combine different causes and severities. Outcomes rely largely on questionnaires; mean scores mask responders and non-responders. The partner is rarely included, even though satisfaction is dyadic.
Trial duration is often too short to judge durability. Studies of supplements and devices may be funded by manufacturers, use multiple analyses or preferentially publish positive results. For shockwave therapy, technical heterogeneity makes the word “treatment” misleading: two clinics may offer devices and doses that are not comparable.
Finally, a statistically significant increase is not necessarily perceptible. Any synthesis must distinguish the mean effect, the confidence interval, the clinical threshold and the associated benefits. Exercise may remain recommended despite a small erectile effect because it also reduces cardiovascular risk; a device that is highly effective technically may be abandoned if it harms spontaneity.
Future directions
Future trials should stratify patients by dominant mechanism, document objective adherence, use couple-centered endpoints and extend follow-up beyond one year. Phenotypes combining vascular health, autonomic function, hormones, sleep and psychosexual factors could predict which intervention responds best.
Digital health can support physical activity, CBT and follow-up, provided that sexual data are protected. Integrated cardiology–urology–sexual medicine programs would use ED as a window for prevention.
Regenerative treatments will have to demonstrate relevant, durable and independent improvement, not merely a change in a biomarker. For shockwave therapy, standardization of devices, dosimetry and sham comparators is indispensable. For the pelvic floor, phenotypes of weakness, hypertonicity and poor coordination need to be identified rather than prescribing the same contractions to everyone.
Conclusion
Treating erectile dysfunction without medication is possible in some men, especially when the condition is mild to moderate, reversibly vasculogenic, lifestyle-related, or strongly maintained by anxiety and the relational context. Regular aerobic activity is the best-supported restorative strategy. Weight loss is relevant only in the presence of excess weight; sex therapy is central in psychogenic or mixed forms; the pelvic floor requires patient selection and supervision; the vacuum erection device is an effective mechanical aid but not a curative one. Shockwave therapy offers at best a modest and uncertain benefit, while supplements justify neither promises nor diagnostic delay.
The useful question, then, is not “which natural remedy replaces a pill?” but “which mechanism predominates, which risk must be treated, and which outcome matters for this person and their partner?”. Personalized management can simultaneously improve sexuality, confidence, physical capacity, and cardiovascular health. Its success is measured as much by the quality of life regained as by rigidity.
Summary table of claims
| Claim | NutriCellScience rating | Main limitation |
|---|---|---|
| ED is a marker of cardiovascular risk | Established | Predictive strength varies with age and phenotype |
| Aerobic exercise improves erectile function | Established | Modest mean effect, blinding impossible |
| Weight loss helps men who are overweight or obese | Probable | Combined interventions; selected subgroups |
| CBT/sex therapy helps psychogenic or mixed forms | Probable | Small and heterogeneous trials |
| Pelvic floor muscle training helps some patients | Emerging to probable | No standardized protocol or phenotype |
| The vacuum erection device produces a usable erection | Established | Variable acceptability and persistence; mechanical effect |
| CPAP directly improves ED in obstructive sleep apnea | Emerging | Small effect and low certainty; primary indication = obstructive sleep apnea |
| Shockwave therapy durably restores function | Emerging | Low certainty, heterogeneity, sometimes imperceptible effect |
| L-arginine or ginseng have a clinically important effect | Emerging | Small effect, heterogeneous products and trials |
| Other “natural aphrodisiacs” treat ED | Hypothetical | Insufficient data and risk of adulteration |
Key verified references
- European Association of Urology. Sexual and Reproductive Health Guidelines: Management of Erectile Dysfunction. Updated 2026. EAU guidelines.
- Köhler TS et al. The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clinic Proceedings. 2024. PubMed.
- Kloner RA et al. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. Journal of Sexual Medicine. 2024. PubMed.
- Khera M et al. Effect of aerobic exercise on erectile function: systematic review and meta-analysis of randomized controlled trials. Journal of Sexual Medicine. 2023;20:1369–1375. PubMed.
- Gupta BP et al. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Archives of Internal Medicine. 2011. PubMed.
- Esposito K et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291:2978–2984. PubMed.
- Esposito K et al. Effects of intensive lifestyle changes on erectile dysfunction in men. Journal of Sexual Medicine. 2009. PubMed.
- Maiorino MI et al. Mediterranean diet and sexual function in people with newly diagnosed type 2 diabetes: the MEDITA trial. Journal of Diabetes and Its Complications. 2016. PubMed.
- Atallah S et al. The effectiveness of psychological interventions alone, or in combination with PDE5 inhibitors, for the treatment of erectile dysfunction: a systematic review. 2021. Full text.
- Wong C et al. A systematic review of pelvic floor muscle training for erectile dysfunction. Sexual Medicine Reviews. 2020. PubMed.
- Kannan P et al. Effectiveness of physiotherapy interventions for improving erectile function: a systematic review and meta-analysis. 2019. PubMed.
- Dorey G et al. Randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunction. British Journal of General Practice. 2004. PubMed.
- Lewis RW, Witherington R. External vacuum therapy for erectile dysfunction: use and results. 1997. PubMed.
- Brison D et al. The resurgence of the vacuum erection device for treatment of erectile dysfunction. Journal of Sexual Medicine. 2013. PubMed.
- Ergun O et al. Low-intensity shockwave therapy for erectile dysfunction. Cochrane Database of Systematic Reviews. 2025. Cochrane summary.
- Hayon S et al. Variations in low-intensity shockwave treatment protocols for erectile dysfunction: a review. 2023. Full text.
- Li Z et al. The effect of CPAP and PDE5 inhibitors on erectile function in men with obstructive sleep apnea: systematic review and meta-analysis. 2019. PubMed.
- Barbosa FT et al. Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea. 2021. PubMed.
- Pourmand G et al. Do cigarette smokers with erectile dysfunction benefit from stopping? A prospective study. 2004. PubMed.
- Karunakaran A et al. Impact of abstinence from alcohol on erectile dysfunction in alcohol dependence. 2022. PubMed.
- Petre GC et al. Dietary supplements for erectile dysfunction: analysis of evidence. 2023. PubMed.
- Leisegang K et al. Alternative medicine and herbal remedies in the treatment of erectile dysfunction: a systematic review. 2021. PubMed.
- Boulenger de Hauteclocque A et al. French AFU/SFMS guidelines for erectile dysfunction. 2024. French guidelines.
Editorial method
This review prioritizes recent international guidelines, systematic reviews, and meta-analyses, then landmark randomized trials. Claims are rated Established, Probable, Emerging, or Hypothetical according to consistency, methodological quality, clinical relevance, and reproducibility. The figures are mean group effects and do not predict individual response. Literature search updated as of July 20, 2026.
Leave a Reply